Laparoendoscopic single-site (LESS) vs laparoscopic living-donor nephrectomy: a systematic review and meta-analysis

2014 ◽  
Vol 115 (2) ◽  
pp. 206-215 ◽  
Author(s):  
Riccardo Autorino ◽  
Luis Felipe Brandao ◽  
Bashir Sankari ◽  
Homayoun Zargar ◽  
Humberto Laydner ◽  
...  
Keyword(s):  
Systematic Review ◽  
Living Donor ◽  
Meta Analysis ◽  
Donor Nephrectomy ◽  
Single Site ◽  
Laparoendoscopic Single Site ◽  
Living Donor Nephrectomy

Safe Initiation of a Laparoendoscopic Single Site Living Donor Nephrectomy Program in a Small-volume Transplant Center

Urology ◽  
2013 ◽  
Vol 82 (2) ◽  
pp. 352-357 ◽  
Author(s):  
Shih-Chieh Jeff Chueh ◽  
Bashir R. Sankari ◽  
Lorie Lipscomb ◽  
Alice M. Jones ◽  
J. Stephen Jones
Keyword(s):  
Living Donor ◽  
Small Volume ◽  
Donor Nephrectomy ◽  
Single Site ◽  
Laparoendoscopic Single Site ◽  
Living Donor Nephrectomy ◽  
Transplant Center

scholarly journals Feasibility, Safety and Efficacy of Enhanced Recovery after Living Donor Nephrectomy: Systematic Review and Meta-Analysis of Randomized Controlled Trials

2020 ◽  
Vol 10 (1) ◽  
pp. 21
Author(s):  
Apostolos Prionas ◽  
Charles Craddock ◽  
Vassilios Papalois
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Living Donor ◽  
Enhanced Recovery ◽  
Meta Analysis ◽  
Donor Nephrectomy ◽  
Controlled Trials ◽  
Randomized Controlled ◽  
Living Donor Nephrectomy

This meta-analysis aims to compare enhanced recovery after surgery (ERAS) vs. standard perioperative practice in the management of living kidney donors. Primary endpoints included mortality, complications, length of stay (LOS) and quality of life after living donor nephrectomy. Medline, Embase, Scopus, Cochrane and Web of Science databases were searched. In total, 3029 records were identified. We then screened 114 full texts. Finally, 11 studies were included in the systematic review corresponding to 813 living donors. Of these, four randomized controlled trials were included in the meta-analysis. ERAS resulted in shorter LOS (95CI: −1.144, −0.078, I2 = 87.622%) and lower incidence of post-operative complications (95CI: 0.158, 0.582, I2 = 0%). This referred to Clavien–Dindo I-II complications (95CI: 0.158, 0.582, I2 = 0%). There was no difference in Clavien–Dindo III-V complications (95CI: 0.061,16.173, I2 = 0%). ERAS donors consumed decreased amounts of narcotics during their hospital stay (95CI: −27.694, −8.605, I2 = 0%). They had less bodily pain (95CI: 6.735, 17.07, I2 = 0%) and improved emotional status (95CI: 6.593,13.319, I2 = 75.682%) one month postoperatively. ERAS protocols incorporating multimodal pain control interventions resulted in a mean reduction of 1 day in donors’ LOS (95CI: −1.374, −0.763, I2 = 0%). Our results suggest that ERAS protocols result in reduced perioperative morbidity, shorter length of hospital stay and improved quality of life after living donor nephrectomy.

scholarly journals First Canadian experience with robotic laparoendoscopic single-site vs. standard laparoscopic living-donor nephrectomy: A prospective comparative study

2018 ◽  
Vol 12 (11) ◽  
Author(s):  
Patrick P. Luke ◽  
Shahid Aquil ◽  
Bijad Alharbi ◽  
Hemant Sharma ◽  
Alp Sener
Keyword(s):  
Body Image ◽  
Functional Outcomes ◽  
Living Donor ◽  
Donor Nephrectomy ◽  
Single Site ◽  
Perioperative Outcomes ◽  
Analgesic Requirement ◽  
Laparoendoscopic Single Site ◽  
Living Donor Nephrectomy ◽  
Significant Difference

Introduction: We aimed to compare the outcomes of robotic laparoendoscopic single-site living donor nephrectomy (R-LESS LDN) vs. standard laparoscopic living donor nephrectomy (LLDN).Methods: Between October 2013 and November 2015, 39 patients were allocated to either standard LLDN (n=25) or R-LESS LDN (n=14). Patient demographics, perioperative outcomes, analgesic requirement, visual analogue scale of pain at postoperative days 1, 3, 7, and 30, and a health-related quality of life and body image questionnaire were prospectively collected.Results: There were no significant differences in demographics and intraoperative outcomes between the two cohorts. The R-LESS LDN cohort had lower analgesic requirement (p=0.002) and lower visual pain scores on days 1 and 3 (p=0.001). Additionally, body image and satisfaction scores in the R-LESS group were also superior compared to the LLDN cohort (p=0.008). There was no significant difference in the postoperative complications according to the Clavien-Dindo system. Recipient graft functional outcomes were equivalent.Conclusions: This is the first evidence that R-LESS LDN is safe and associated with comparable surgical and early functional outcomes compared to LLDN, while pain, donor body image, and satisfaction scores were improved compared to LLDN.

Indications for additional port placement in laparoendoscopic single site (LESS) living donor nephrectomy

2011 ◽  
Vol 213 (3) ◽  
pp. S150
Author(s):  
Jinny S. Ha ◽  
Michael Phelan ◽  
Matthew Cooper ◽  
Sameh Fayek ◽  
Raghava Munivenkatappa ◽  
...  
Keyword(s):  
Living Donor ◽  
Donor Nephrectomy ◽  
Single Site ◽  
Port Placement ◽  
Laparoendoscopic Single Site ◽  
Living Donor Nephrectomy ◽  
Additional Port
Sign in / Sign up

Export Citation Format

Share Document